Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03119233 · ClinicalTrials.gov registry record · NA
The DETOUR 2 Clinical Trial
A NA study, sponsored by Endologix.
- Completed
- Registry status
- NA
- Development phase
- 202
- Enrollment target
NCT03119233 is a NA study that has completed, run by Endologix. The registered enrollment target is 202 participants.
The verdict
NCT03119233, a NA study, has completed, sponsored by Endologix.
- COMPLETED
- Registry status
- NA
- Development phase
- 202 participants
- Enrollment target
Study Summary
Prospective, single-arm, multi-center, international clinical investigation to evaluate the safety and effectiveness of the PQ Bypass System to access, deliver guidewires, and implant stent grafts for a percutaneous femoropopliteal (fem-pop) bypass.
Interventions
- DEVICE DETOUR System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2017-12-13 |
| Est. Completion | 2023-11-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03119233
The ClinicalTrials.gov registry entry for NCT03119233 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endologix, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DETOUR System is the first listed.
NCT03119233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03119233 about?
NCT03119233 is a clinical study titled "The DETOUR 2 Clinical Trial". Prospective, single-arm, multi-center, international clinical investigation to evaluate the safety and effectiveness of the PQ Bypass System to access, deliver guidewires, and implant stent grafts for a percutaneous femoropopliteal (fem-pop) bypass.
What is the current status of trial NCT03119233?
This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2017-12-13. Estimated completion is 2023-11-13.
What interventions are being tested in trial NCT03119233?
The interventions under investigation include: DETOUR System (DEVICE).
Who is sponsoring clinical trial NCT03119233?
This trial is sponsored by Endologix, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.